Deutsch  English

Publikationen / Arbeitsgruppe Neuro- und Tumorzellbiologie

Murmann T., Carrillo-García C., Veit N., Courts C., Glassmann A., Janzen V., Madea B., Reinartz M., Harzen A., Nowak M., Perner S., Winter J., Probstmeier R. (2014) Staurosporine and extracellular matrix proteins mediate the conversion of small cell lung carcinoma cells into a neuron-like phenotype. PLoS ONE 9(2): e86910. doi:10.1371/journal.pone.0086910.

 

Glassmann, A., Reichmann ,K., Scheffler, B., Glas, M., Veit, N., and Probstmeier, R. (2011) Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration. Int. J. Oncol. 39:1567-1575.

 

Vladimirova, V., Waha, A., Lückerath, K., Pesheva, P., and Probstmeier, R. (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J. Neurosci. Res. 86: 2450-2461.

 

Pesheva, P., Probstmeier, R., Lang, D.M., McBride, R., Hsu, N.-J., Gennarini, G., Spiess, E., and Peshev, Z. (2006) Early coevolution of adhesive but not antiadhesive tenascin-R ligand-receptor pairs in vertebrates: a phylogenetic study. Mol. Cell. Neurosci. 32: 366-386.

 

Pesheva P., Probstmeier R. (2006) Tenascin-R trifft Oligodendrozyten: eine stabile Beziehung.

BIOforum 1/2006: 26-28.

 

Kuklinski, S., Vladimirova, V., Waha, A., Kamata, H., Pesheva, P., and Probstmeier, R. (2003) Expression of galectin-3 in neuronally differentiating PC12 cells is regulated via both Ras/MAPK-dependent and –independent signalling pathways. J. Neurochem. 87, 1112-1124.

 

Pesheva, P., Nellen, J., Biersack, H.-J., and Probstmeier, R. (2002) Galectin-3 is expressed during peripheral nerve development: dependence on the Schwann cell phenotype. Neurosci. Res. Commun. 30, 71-82.

 

Pesheva, P., Gloor, S., and Probstmeier, R. (2001) Tenascin-R as a regulator of CNS glial cell function. In: Glial Cell Function (Nieto-Sampedro M, Castellano B, eds), Amsterdam: Elsevier Science B.V.; Progress Brain Res. 132: 103-114.

 

Probstmeier, R., Nellen, J., Gloor, S., Wernig, A., and Pesheva, P. (2001) Tenascin-R is expressed by Schwann cells in the peripheral nervous system. J. Neurosci. Res. 64, 70-78.

 

Pesheva, P., Kuklinski, S., Biersack, H.-J., and Probstmeier, R. (2000) NGF-mediated expression of galectin-3 in mouse dorsal root ganglion neurons. Neurosci. Lett. 293, 37-40.

 

Walther, M., Kuklinski, S., Pesheva, P., Guntinas-Lichius, O., Angelov, D., Neiss, W., Asou, H., and Probstmeier, R. (2000) Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions but not to facial nerve axotomy. J. Neurosci. Res. 61, 430-435.

 

Dohm, S., Streppel, M., Guntinas-Lichius, O.G., Pesheva, P., Probstmeier, R., Walther, M., Neiss, W. F., Stennert, E., and Angelov, D. (2000) Identical pattern of axon branching after varying reconstructive surgery on rat facial nerve. Local application of extracellular matrix proteins fails to reduce axon branches during regeneration. Rest. Neurol. Neurosci. 16, 117-126.

 

• Probstmeier, R., Braunewell, K.-H., and Pesheva, P. (2000a) Involvement of chondroitin sulfates on brain-derived tenascin-R in carbohydrate-dependent interactions with fibronectin and tenascin-C. Brain Res. 863, 42-51.

 

• Probstmeier, R., Stichel, C.C., Müller, H.W., Asou, H., and Pesheva, P. (2000b) Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition - functional implications during CNS development and regeneration. J. Neurosci. Res. 60, 21-36.

 

• Pesheva, P. and Probstmeier, R. (2000a) Association of tenascin-R with brain myelin membranes: involvement of divalent cations. Neurosci. Lett. 283, 165-168.

 

• Pesheva, P. and Probstmeier, R. (2000b) The yin and yang of tenascin-R in CNS development and pathology. Prog. Neurobiol. 61, 465-493.

 

• Kuklinski, S., Pesheva, P., Heimann, C., Urschel, S., Gloor, S., Graeber, S., Herzog, V., Pietsch, T., Wiestler, O., and Probstmeier, R. (2000) Expression pattern of galectin-3 in neural tumor cell lines. J. Neurosci. Res. 60, 45-57.

 

Terminvergabe

Bitte vereinbaren Sie telefonisch einen Termin.

Schilddrüsenambulanz:
Tel.: +49 (0) 228 / 287-16171

Fax: +49 (0) 228 / 287-16615

PET/CT:
Tel.: +49 (0) 228 / 287 - 11088
Fax: +49 (0) 228 / 287-16207

Konventionelle Szintigraphie:
Tel.: +49 (0) 228 / 287-16171

Therapie-Sekretariat:
Tel.: +49 (0) 228 / 287-16974

Fax: +49 (0) 228 / 287-19057

Therapiestation Winkler:
Tel.: +49 (0) 228 / 287-16855
Fax: +49 (0) 228 / 287-19107

 

Befundabfrage:

Mo. - Do.: 08:00 Uhr - 16:00 Uhr

Fr.: 08:00 Uhr - 13:00 Uhr

Tel.: +49 (0)228 / 287 - 15181

Fax: +49 (0)228 / 287 - 19096

klinik.nuklearmedizin@ukbonn.de

 

 

Klinik und Poliklinik für Nuklearmedizin

Universitätsklinikum Bonn (AöR)

Sigmund-Freud-Straße 25

D-53127 Bonn